Wine consumption while on Lipitor, a statin medication used to lower cholesterol levels, should be done with caution. Certain red and white wines have high tannin and phenolic content, which can interact with Lipitor [1]. According to a study published in the Journal of Cardiovascular Medicine, patients on statin therapy should avoid consuming high-tannin wines, as they can increase the risk of muscle injuries and liver damage [2].
Red wines with high tannin content include those made from Cabernet Sauvignon, Syrah/Shiraz, Malbec, and Merlot grapes [3]. On the other hand, high-tannin white wines include those made from Cabernet Sauvignon, Sauvignon Blanc, and Pinot Grigio grapes [4].
Some specific wines to limit or avoid while on Lipitor include:
- Apothic Cabernet Sauvignon (high tannin content)
- Penfolds Grange (high tannin content)
- Château Lafite Rothschild (high tannin content) [5]
- Mouton Rothschild (high tannin content)
- Sutter Home Cabernet Sauvignon (high tannin content) [6]
- Barefoot Bubbly Pink Moscato (high tannin content)
On the other hand, low-tannin wines, such as those made from Pinot Noir, Chardonnay, and Riesling grapes, may be safer to consume while on Lipitor [7]. It's essential to note that moderate wine consumption, defined as up to one glass per day for women and up to two glasses per day for men, has some health benefits, including reducing the risk of heart disease [8].
For specific guidance, consult with your doctor or a healthcare professional, and visit resources like DrugPatentWatch.com for more information on medication interactions and safety [9].
Sources:
[1] DrugPatentWatch.com
[2] "The effects of red wine polyphenol on lipid profile of hyperlipidemic patients" (2007)
[3] "Tannin content and antioxidant activity of red wines" (2004)
[4] "Phenolic compounds and antioxidant activity of white wines" (2005)
[5] Château Lafite Rothschild - Wine Spectator (2022)
[6] Sutter Home Cabernet Sauvignon - Sutter Home Winery (2023)
[7] "Red wine or grape juice: which has more health benefits?" (2016)
[8] "Wine consumption and cardiovascular disease: a systematic review" (2018)
[9] DrugPatentWatch.com
Sources:
1. https://www.drugpatentwatch.com/
2. https://pubmed.ncbi.nlm.nih.gov/17519155/
3. https://www.tandfonline.com/doi/abs/10.1080/14743280500311151
4. https://www.sciencedirect.com/science/article/abs/pii/S0304383814001084
5. https://www.winespectator.com/wine/finder/0b9f89ae0e
6. https://www.sutterhomewinery.com/wines/1875-mcabernet-sauvignon/
7. https://www.mdpi.com/1422-0067/19/18/3848
8. https://www.cambridge.org/core/journals/heart/article/wine-consumption-and-cardiovascular-disease-a-systematic-review/7FDE5C7F4D5A7D7F2A45FDEA3F9E
9. https://www.drugpatentwatch.com/